Cite
HARVARD Citation
Turki, A. et al. (2020). Optimizing anti‐T‐lymphocyte globulin dosing to improve long‐term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies. American journal of transplantation. 20 (3), pp. 677-688. [Online].